Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Showing 1 to 6 of 6 results for patent foramen ovale

  1. Percutaneous closure of patent foramen ovale to prevent recurrent cerebral embolic events (IPG472)

    Evidence-based recommendations on percutaneous closure of the patent foramen ovale for the prevention of cerebral embolic stroke. This involves placing a small device into the heart to close the hole.

    Interventional procedures guidance
    Published
    18 December 2013
    View recommendations

    Sections for IPG472

  2. Percutaneous closure of patent foramen ovale for recurrent migraine (IPG370)

    Evidence-based recommendations on percutaneous closure of patent foramen ovale for recurrent migraine. This involves passing a device through a large vessel in the groin up into the heart and closing/blocking the hole in the wall of the heart.

    Interventional procedures guidance
    Published
    15 December 2010
    View recommendations

    Sections for IPG370

  3. Percutaneous closure of patent foramen ovale for the secondary prevention of recurrent paradoxical embolism in divers (IPG371)

    Evidence-based recommendations on percutaneous closure of patent foramen ovale for the secondary prevention of recurrent paradoxical embolism in divers. This involves passing a device through a large vessel in the groin up into the heart and closing/blocking the hole in the wall.

    Interventional procedures guidance
    Published
    15 December 2010
    View recommendations

    Sections for IPG371

  4. Ultrasound-guided foam sclerotherapy for varicose veins (IPG440)

    Evidence-based recommendations on ultrasound guided foam sclerotherapy for varicose veins. This involves mixing a chemical with air or another gas to produce a foam, which is injected into the affected vein using ultrasound imaging to monitor its progress.

    Interventional procedures guidance
    Published
    23 February 2013
    View recommendations

    Sections for IPG440

  5. Percutaneous closure of patent foramen ovale for the secondary prevention of recurrent paradoxical embolism (IPG109)

    This guidance has been replaced by NICE interventional procedure guidance 472.

    Interventional procedures guidance
    Published
    23 January 2005

  6. Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke (DG41)

    Evidence-based recommendations on implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke

    Diagnostics guidance
    Published
    2 September 2020
    View recommendations

    Sections for DG41